Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $284.09 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $65.21 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $55.37 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.32 | 1 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $22.27 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $21.91 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $19.24 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.07 | 1 | $0 (2022) |
| Lilly USA, LLC | $16.45 | 1 | $0 (2022) |
| Lundbeck LLC | $15.69 | 1 | $0 (2023) |
| Exact Sciences Corporation | $15.29 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.10 | 6 | AstraZeneca Pharmaceuticals LP ($21.91) |
| 2023 | $85.45 | 5 | GlaxoSmithKline, LLC. ($27.98) |
| 2022 | $98.54 | 5 | ABBVIE INC. ($28.46) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Oncology | ||||||
| 12/06/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 03/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: DIABETES | ||||||
| 07/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 664 | 1,674 | $87,484 | $26,461 |
| 2022 | 10 | 432 | 859 | $53,794 | $19,756 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 391 | $49,989 | $18,672 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $4,665 | $2,548 | 54.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 40 | 46 | $4,600 | $1,593 | 34.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 81 | 188 | $8,460 | $1,357 | 16.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 27 | 62 | $3,224 | $1,006 | 31.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 39 | 43 | $1,376 | $332.24 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 36 | $360.00 | $302.40 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $275.00 | $269.50 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 37 | $370.00 | $126.17 | 34.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 46 | 268 | $5,360 | $91.10 | 1.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 64 | 85 | $1,700 | $58.91 | 3.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 37 | 49 | $1,225 | $51.44 | 4.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 22 | 104 | $2,600 | $28.52 | 1.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 62 | 328 | $3,280 | $25.71 | 0.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 263 | $33,664 | $14,788 | 43.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 37 | 39 | $3,900 | $1,569 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,285 | $1,437 | 43.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 29 | 65 | $3,380 | $1,024 | 30.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 57 | 89 | $4,005 | $695.54 | 17.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 22 | 29 | $290.00 | $99.17 | 34.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 19 | $190.00 | $55.95 | 29.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 27 | 132 | $2,640 | $41.43 | 1.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 39 | 42 | $840.00 | $32.68 | 3.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 36 | 160 | $1,600 | $13.21 | 0.8% |
About Cherity Burrows, APRN-CNP
Cherity Burrows, APRN-CNP is a Family healthcare provider based in Altus, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1285977801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cherity Burrows, APRN-CNP has received a total of $284.09 in payments from pharmaceutical and medical device companies, with $100.10 received in 2024. These payments were reported across 16 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($284.09).
As a Medicare-enrolled provider, Burrows has provided services to 1,096 Medicare beneficiaries, totaling 2,533 services with total Medicare billing of $46,217. Data is available for 2 years (2022–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Altus, OK
- Active Since 04/02/2013
- Last Updated 10/26/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285977801
Products in Payments
- TRELEGY ELLIPTA (Drug) $55.37
- JARDIANCE (Drug) $38.77
- UBRELVY (Drug) $28.46
- GVOKE HYPOPEN (Drug) $22.27
- AIRSUPRA (Drug) $21.91
- VRAYLAR (Drug) $19.51
- Auvelity (Drug) $19.24
- VIBERZI (Drug) $17.24
- TRINTELLIX (Drug) $17.07
- REXULTI (Drug) $15.69
- Cologuard Collection Kit (Device) $15.29
- LEQVIO (Drug) $13.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Altus
Mrs. Kristi Fry, Aprn, APRN
Family — Payments: $1,679
Kimberly Cline, Aprn-Cnp, APRN-CNP
Family — Payments: $1,192
Brandy Vermillion, Aprn-Cnp, APRN-CNP
Family — Payments: $504.14
Mrs. Frances Barber, Msn, Aprn-Cnp, Fnp-C, MSN, APRN-CNP, FNP-C
Family — Payments: $120.48
Monte Combs
Family — Payments: $45.42
Brita Angelone, Arnp, ARNP
Family — Payments: $26.50